Fresenius SE & Co. KGaA (FRE) - Net Assets

Latest as of September 2025: €19.27 Billion EUR ≈ $22.53 Billion USD

Based on the latest financial reports, Fresenius SE & Co. KGaA (FRE) has net assets worth €19.27 Billion EUR (≈ $22.53 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€42.46 Billion ≈ $49.64 Billion USD) and total liabilities (€23.19 Billion ≈ $27.11 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Fresenius SE & Co. KGaA tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€19.27 Billion
% of Total Assets	45.38%
Annual Growth Rate	8.5%
5-Year Change	-22.03%
10-Year Change	7.07%
Growth Volatility	30.53

Fresenius SE & Co. KGaA - Net Assets Trend (2002–2024)

This chart illustrates how Fresenius SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. See FRE defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Fresenius SE & Co. KGaA (2002–2024)

The table below shows the annual net assets of Fresenius SE & Co. KGaA from 2002 to 2024. For live valuation and market cap data, see market cap of Fresenius SE & Co. KGaA.

Year	Net Assets	Change
2024-12-31	€20.29 Billion ≈ $23.72 Billion	+3.25%
2023-12-31	€19.65 Billion ≈ $22.97 Billion	-39.01%
2022-12-31	€32.22 Billion ≈ $37.67 Billion	+10.00%
2021-12-31	€29.29 Billion ≈ $34.24 Billion	+12.55%
2020-12-31	€26.02 Billion ≈ $30.42 Billion	-2.10%
2019-12-31	€26.58 Billion ≈ $31.07 Billion	+6.29%
2018-12-31	€25.01 Billion ≈ $29.24 Billion	+15.14%
2017-12-31	€21.72 Billion ≈ $25.39 Billion	+0.54%
2016-12-31	€21.60 Billion ≈ $25.26 Billion	+14.01%
2015-12-31	€18.95 Billion ≈ $22.15 Billion	+17.24%
2014-12-31	€16.16 Billion ≈ $18.90 Billion	+17.71%
2013-12-31	€13.73 Billion ≈ $16.05 Billion	+4.38%
2012-12-31	€13.16 Billion ≈ $15.38 Billion	+24.38%
2011-12-31	€10.58 Billion ≈ $12.37 Billion	+19.60%
2010-12-31	€8.84 Billion ≈ $10.34 Billion	+15.58%
2009-12-31	€7.65 Billion ≈ $8.95 Billion	+10.21%
2008-12-31	€6.94 Billion ≈ $8.12 Billion	+108.00%
2007-12-31	€3.34 Billion ≈ $3.90 Billion	+7.61%
2006-12-31	€3.10 Billion ≈ $3.63 Billion	+11.74%
2005-12-31	€2.78 Billion ≈ $3.25 Billion	+73.18%
2004-12-31	€1.60 Billion ≈ $1.87 Billion	-50.12%
2003-12-31	€3.21 Billion ≈ $3.76 Billion	-4.60%
2002-12-31	€3.37 Billion ≈ $3.94 Billion	--

Equity Component Analysis

This analysis shows how different components contribute to Fresenius SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1403800000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	€14.04 Billion	71.84%
Common Stock	€563.00 Million	2.88%
Other Comprehensive Income	€626.00 Million	3.20%
Other Components	€4.32 Billion	22.08%
Total Equity	€19.54 Billion	100.00%

Fresenius SE & Co. KGaA Competitors by Market Cap

The table below lists competitors of Fresenius SE & Co. KGaA ranked by their market capitalization.

Company	Market Cap
ABN AMRO BK.UNSP.ADR/1 F:AB2A	$23.71 Billion
BK MANDIRI (PE).ADR/20 ON F:PQ90	$23.73 Billion
Bunge Limited NYSE:BG	$23.75 Billion
TechnipFMC PLC F:1T1	$23.79 Billion
Reddit, Inc. NYSE:RDDT	$23.67 Billion
Novonesis (Novozymes) A/S CO:NSIS-B	$23.64 Billion
First Solar Inc NASDAQ:FSLR	$23.63 Billion
Sigma Healthcare Ltd AU:SIG	$23.61 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Fresenius SE & Co. KGaA's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 18,999,000,000 to 19,542,000,000, a change of 543,000,000 (2.9%).
Net income of 471,000,000 contributed positively to equity growth.
Other comprehensive income increased equity by 608,000,000.
Other factors decreased equity by 536,000,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€471.00 Million	+2.41%
Other Comprehensive Income	€608.00 Million	+3.11%
Other Changes	€-536.00 Million	-2.74%
Total Change	€-	2.86%

Book Value vs Market Value Analysis

This analysis compares Fresenius SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.04x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2002-12-31	€-1.26	€35.96	x
2003-12-31	€-1.15	€35.96	x
2004-12-31	€12.98	€35.96	x
2005-12-31	€21.88	€35.96	x
2006-12-31	€6.68	€35.96	x
2007-12-31	€7.10	€35.96	x
2008-12-31	€8.19	€35.96	x
2009-12-31	€8.78	€35.96	x
2010-12-31	€10.15	€35.96	x
2011-12-31	€12.09	€35.96	x
2012-12-31	€14.55	€35.96	x
2013-12-31	€15.16	€35.96	x
2014-12-31	€17.12	€35.96	x
2015-12-31	€19.91	€35.96	x
2016-12-31	€22.69	€35.96	x
2017-12-31	€24.46	€35.96	x
2018-12-31	€27.60	€35.96	x
2019-12-31	€30.10	€35.96	x
2020-12-31	€30.39	€35.96	x
2021-12-31	€34.04	€35.96	x
2022-12-31	€36.37	€35.96	x
2023-12-31	€33.73	€35.96	x
2024-12-31	€34.70	€35.96	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Fresenius SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.41%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.16%
• Asset Turnover: 0.50x
• Equity Multiplier: 2.23x
Recent ROE (2.41%) is below the historical average (10.54%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2002	0.00%	1.79%	0.84x	0.00x	€149.50 Million
2003	0.00%	1.63%	0.85x	0.00x	€129.20 Million
2004	10.48%	2.31%	0.89x	5.11x	€7.70 Million
2005	8.00%	2.81%	0.68x	4.18x	€-55.60 Million
2006	10.64%	3.06%	0.72x	4.84x	€19.80 Million
2007	12.28%	3.61%	0.74x	4.59x	€76.20 Million
2008	6.91%	2.19%	0.60x	5.25x	€-121.00 Million
2009	23.21%	7.00%	0.68x	4.89x	€564.00 Million
2010	24.27%	7.54%	0.68x	4.75x	€708.50 Million
2011	22.24%	8.04%	0.63x	4.41x	€730.90 Million
2012	12.13%	4.80%	0.63x	4.02x	€162.70 Million
2013	12.34%	4.97%	0.62x	4.00x	€191.50 Million
2014	11.43%	4.59%	0.58x	4.27x	€133.50 Million
2015	12.42%	4.92%	0.64x	3.95x	€264.50 Million
2016	12.74%	5.48%	0.63x	3.71x	€342.70 Million
2017	13.28%	5.35%	0.64x	3.89x	€447.90 Million
2018	13.15%	6.05%	0.59x	3.68x	€485.90 Million
2019	11.22%	5.32%	0.53x	3.99x	€205.20 Million
2020	10.07%	4.71%	0.54x	3.93x	€12.10 Million
2021	9.57%	4.85%	0.52x	3.79x	€-81.80 Million
2022	6.72%	3.36%	0.53x	3.74x	€-669.50 Million
2023	-3.13%	-2.66%	0.49x	2.38x	€-2.49 Billion
2024	2.41%	2.16%	0.50x	2.23x	€-1.48 Billion

Industry Comparison

This section compares Fresenius SE & Co. KGaA's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $5,263,159,421
Average return on equity (ROE) among peers: 2.64%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Fresenius SE & Co. KGaA (FRE)	€19.27 Billion	0.00%	1.20x	$23.68 Billion
China Resources Medical Holdings Company Limited (1PH)	$6.34 Billion	4.89%	0.41x	$419.83 Million
AEST.MED.INT.HLD.SP.ADR/3 (3FMA)	$-186.42 Million	0.00%	0.00x	$3.30 Million
JINXIN FERT.GRP HD-00001 (3NX)	$10.19 Billion	3.38%	0.46x	$656.44 Million
REVITALIST L.A.W. LTD (4DO)	$-11.05 Million	0.00%	0.00x	$744.60K
Wenzhou Kangning Hospital Co. Ltd (4WK)	$1.21 Billion	6.69%	0.53x	$18.46 Million
HYGEIA HC HLDGS DL-00001 (50I)	$6.78 Billion	2.43%	0.57x	$11.93K
COMPASS PATHW SP.ADR (5Y6)	$284.41 Million	-25.22%	0.06x	$657.30 Million
Bumrungrad Hospital Public Company Limited (BZ7A)	$14.79 Billion	24.52%	0.44x	$49.74K
Eifelhöhen-Klinik AG (EIF)	$12.61 Million	0.67%	1.87x	$10.05 Million
Fresenius Medical Care AG & Co. KGaA (FME)	$13.23 Billion	9.07%	1.49x	$10.01 Billion

About Fresenius SE & Co. KGaA

XETRA:FRE Germany Medical Care Facilities

Market Cap

$23.68 Billion

€20.25 Billion EUR

Market Cap Rank

#1112 Global

#257 in Germany

Share Price

€35.96

Change (1 day)

-1.34%

52-Week Range

€35.45 - €52.12

All Time High

€68.67